Aveanna reports Q2 adjusted EPS 18c, consensus 4c

Reports Q2 revenue $589.6M, consensus $535.34M. CEO Jeff Shaner commented, “Our second quarter results reflect the continued positive momentum in all three operating divisions as we navigate the third year of our Strategic Transformation. The quarter was highlighted by revenue and adjusted EBITDA growth of 16.8% and 93.6%, respectively, when compared to the prior year period. We continue to advocate for our patients and families to receive the value of high-quality health care in the comfort of their home. 2025 is shaping up to be a great year for Aveanna (AVAH), and our revised guidance demonstrates the momentum we have in our business.” CFO Matt Buckhalter commented “Our Q2 results are highlighted by revenue and Adjusted EBITDA growth of 16.8% and 93.6%, respectively, compared to the prior year. Our team’s relentless focus on operational excellence, disciplined execution, and delivering strong clinical outcomes continues to drive our improved results. In addition, our successful acquisition of Thrive Skilled Pediatric Care expands both the scale and capabilities of our pediatric services. Based on our performance and the opportunities ahead, we are pleased to raise our full-year 2025 guidance to revenue of greater than $2.3B and Adjusted EBITDA of greater than $270M.”